Risk of rectal bleeding with endorectal balloon use after hypofractionated intensity‐modulated radiotherapy for prostate cancer

Endorectal balloon use during moderately hypofractionated IMRT was associated with significantly greater rectal bleeding, while oncological outcomes did not differ significantly. In the absence of demonstrated patient benefit, our findings do not support the routine use of ERB in contemporary prostate radiotherapy.